ALUMINUM BETA-CYCLODEXTRIN SULFATE AS A STABILIZER AND SUSTAINED-RELEASE CARRIER FOR BASIC FIBROBLAST GROWTH-FACTOR

被引:20
作者
FUKUNAGA, K
HIJIKATA, S
ISHIMURA, K
SONODA, R
IRIE, T
UEKAMA, K
机构
[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,KUMAMOTO 862,JAPAN
[2] KAKEN PHARMACEUT CO LTD,DEPT DRUG FORMULAT,FUJIEDA,SHIZUOKA 426,JAPAN
关键词
D O I
10.1111/j.2042-7158.1994.tb03771.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The water-insoluble aluminium salt of beta-cyclodextrin sulphate (Al.beta-CyD-Sul) was used as a stabilizer and sustained-release carrier for recombinant human basic fibroblast growth factor (bFGF). An adsorbate of bFGF with Al.beta-CyD-Sul was prepared by incubating the protein with a suspension of Al.beta-CyD-Sul in water. The mitogenic activity of bFGF released from the adsorbate, as indicated by the proliferation of kidney cells of baby hamster (BHK-21), was almost comparable with that of the intact bFGF. Al.beta-CyD-Sul significantly protected bFGF from proteolytic degradation by pepsin and alpha-chymotrypsin, compared with the water-soluble sodium salt. The in-vitro release of bFGF from the adsorbate was sustained in proportion to a rise in the ratio of Al.beta-CyD-Sul to the protein in the adsorbate. Of the bFGF preparations evaluated, the adsorbate of bFGF with Al.beta-CyD-Sul, when given subcutaneously to the rat, showed the most prominent increase in the formation of granulation tissues, due to the stabilization and slow-release of the mitogen. The limited data presented here suggest that the adsorbate of bFGF with Al.beta-CyD-Sul has a potent therapeutic efficacy for wound healing, and may be applicable to oral protein formulations for the treatment of intestinal mucosal erosions.
引用
收藏
页码:168 / 171
页数:4
相关论文
共 19 条
[1]   USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN AS A SOLUBILIZING AND STABILIZING EXCIPIENT FOR PROTEIN DRUGS [J].
BREWSTER, ME ;
HORA, MS ;
SIMPKINS, JW ;
BODOR, N .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :792-795
[2]   STIMULATION OF WOUND-HEALING, USING BRAIN EXTRACT WITH FIBROBLAST GROWTH-FACTOR (FGF) ACTIVITY .1. QUANTITATIVE AND BIOCHEMICAL-STUDIES INTO FORMATION OF GRANULATION-TISSUE [J].
BUNTROCK, P ;
JENTZSCH, KD ;
HEDER, G .
EXPERIMENTAL PATHOLOGY, 1982, 21 (01) :46-53
[3]   ACCELERATED WOUND REPAIR, CELL-PROLIFERATION, AND COLLAGEN ACCUMULATION ARE PRODUCED BY A CARTILAGE-DERIVED GROWTH-FACTOR [J].
DAVIDSON, JM ;
KLAGSBRUN, M ;
HILL, KE ;
BUCKLEY, A ;
SULLIVAN, R ;
BREWER, PS ;
WOODWARD, SC .
JOURNAL OF CELL BIOLOGY, 1985, 100 (04) :1219-1227
[4]   CONTROL OF ANGIOGENESIS WITH SYNTHETIC HEPARIN SUBSTITUTES [J].
FOLKMAN, J ;
WEISZ, PB ;
JOULLIE, MM ;
LI, WW ;
EWING, WR .
SCIENCE, 1989, 243 (4897) :1490-1493
[5]   HEPARAN-SULFATE IN THE BINDING AND ACTIVATION OF BASIC FIBROBLAST GROWTH-FACTOR [J].
GALLAGHER, JT ;
TURNBULL, JE .
GLYCOBIOLOGY, 1992, 2 (06) :523-528
[6]   STRUCTURAL CHARACTERIZATION AND BIOLOGICAL FUNCTIONS OF FIBROBLAST GROWTH-FACTOR [J].
GOSPODAROWICZ, D ;
FERRARA, N ;
SCHWEIGERER, L ;
NEUFELD, G .
ENDOCRINE REVIEWS, 1987, 8 (02) :95-114
[7]   HEPARIN PROTECTS BASIC AND ACIDIC FGF FROM INACTIVATION [J].
GOSPODAROWICZ, D ;
CHENG, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (03) :475-484
[8]   STABILIZATION OF BASIC FIBROBLAST GROWTH-FACTOR WITH DEXTRAN SULFATE [J].
KAJIO, T ;
KAWAHARA, K ;
KATO, K .
FEBS LETTERS, 1992, 306 (2-3) :243-246
[9]  
KATO K, 1990, PRODUCTION COMPOSITI
[10]  
NAGASHIMA R, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1668